CME Group (NASDAQ:CME) Price Target Cut to $235.00 by Analysts at Piper Sandler

CME Group (NASDAQ:CMEGet Free Report) had its price target reduced by research analysts at Piper Sandler from $250.00 to $235.00 in a note issued to investors on Tuesday, Benzinga reports. The firm presently has an “overweight” rating on the financial services provider’s stock. Piper Sandler’s price objective suggests a potential upside of 21.40% from the stock’s previous close.

Other equities research analysts also recently issued research reports about the stock. Rosenblatt Securities reaffirmed a “sell” rating and set a $187.00 price target (up previously from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Morgan Stanley increased their target price on shares of CME Group from $222.00 to $225.00 and gave the company an “equal weight” rating in a research note on Tuesday, April 9th. JPMorgan Chase & Co. downgraded shares of CME Group from a “neutral” rating to an “underweight” rating and reduced their target price for the company from $206.00 to $187.00 in a research note on Friday, June 21st. Deutsche Bank Aktiengesellschaft reissued a “hold” rating and issued a $210.00 target price (down previously from $235.00) on shares of CME Group in a research note on Friday, April 5th. Finally, Barclays increased their target price on shares of CME Group from $226.00 to $228.00 and gave the company an “equal weight” rating in a research note on Thursday, April 25th. Three research analysts have rated the stock with a sell rating, six have assigned a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and an average target price of $217.64.

View Our Latest Report on CME Group

CME Group Price Performance

CME Group stock opened at $193.58 on Tuesday. The company has a market cap of $69.70 billion, a price-to-earnings ratio of 22.02, a PEG ratio of 5.15 and a beta of 0.52. The firm’s fifty day moving average is $202.67 and its 200 day moving average is $207.71. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 0.10. CME Group has a 52-week low of $180.11 and a 52-week high of $223.80.

CME Group (NASDAQ:CMEGet Free Report) last released its quarterly earnings results on Wednesday, April 24th. The financial services provider reported $2.50 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.44 by $0.06. The company had revenue of $1.49 billion for the quarter, compared to the consensus estimate of $1.48 billion. CME Group had a net margin of 56.84% and a return on equity of 12.45%. CME Group’s revenue was up 3.2% on a year-over-year basis. During the same quarter in the prior year, the firm earned $2.42 earnings per share. Sell-side analysts forecast that CME Group will post 9.74 EPS for the current fiscal year.

Insider Activity at CME Group

In other CME Group news, Director Daniel R. Glickman sold 650 shares of the firm’s stock in a transaction dated Thursday, June 6th. The shares were sold at an average price of $201.44, for a total transaction of $130,936.00. Following the transaction, the director now owns 14,008 shares of the company’s stock, valued at approximately $2,821,771.52. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, insider Hilda Harris Piell sold 7,140 shares of CME Group stock in a transaction that occurred on Wednesday, May 8th. The shares were sold at an average price of $210.35, for a total value of $1,501,899.00. Following the transaction, the insider now owns 29,256 shares of the company’s stock, valued at approximately $6,153,999.60. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Daniel R. Glickman sold 650 shares of CME Group stock in a transaction that occurred on Thursday, June 6th. The stock was sold at an average price of $201.44, for a total transaction of $130,936.00. Following the completion of the transaction, the director now directly owns 14,008 shares in the company, valued at approximately $2,821,771.52. The disclosure for this sale can be found here. Insiders sold 54,290 shares of company stock worth $11,393,700 in the last 90 days. 0.30% of the stock is owned by corporate insiders.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently modified their holdings of the company. B. Riley Wealth Advisors Inc. grew its position in shares of CME Group by 1.3% in the 4th quarter. B. Riley Wealth Advisors Inc. now owns 3,625 shares of the financial services provider’s stock worth $782,000 after buying an additional 48 shares during the last quarter. Capital Advisors Ltd. LLC grew its position in CME Group by 4.3% during the 1st quarter. Capital Advisors Ltd. LLC now owns 1,160 shares of the financial services provider’s stock worth $250,000 after purchasing an additional 48 shares during the last quarter. Lantz Financial LLC grew its position in CME Group by 1.1% during the 1st quarter. Lantz Financial LLC now owns 4,561 shares of the financial services provider’s stock worth $982,000 after purchasing an additional 49 shares during the last quarter. Transcend Capital Advisors LLC grew its position in CME Group by 1.7% during the 4th quarter. Transcend Capital Advisors LLC now owns 2,995 shares of the financial services provider’s stock worth $631,000 after purchasing an additional 50 shares during the last quarter. Finally, Greystone Financial Group LLC grew its position in CME Group by 1.6% during the 4th quarter. Greystone Financial Group LLC now owns 3,282 shares of the financial services provider’s stock worth $691,000 after purchasing an additional 52 shares during the last quarter. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Analyst Recommendations for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.